Scott Dylla
Directeur/Bestuurslid bij KINETA, INC.
Vermogen: 1 860 $ op 31-05-2024
Actieve functies van Scott Dylla
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KINETA, INC. | Directeur/Bestuurslid | 01-07-2023 | - |
| Independent Dir/Board Member | 01-07-2023 | - | |
Driver Bioengineering, Inc.
 Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Voorzitter | 01-06-2019 | - |
| Directeur/Bestuurslid | 01-06-2019 | - | |
3D Bio Holdings, Inc.
 3D Bio Holdings, Inc. Packaged SoftwareTechnology Services 3D Bio Holdings, Inc. develops term clinical applications. It focuses on whole tissue living implants. The company was founded by Hod Lipson, Larry Bonassar and Daniel L. Cohen and is headquartered in Brooklyn, NY. | Directeur/Bestuurslid | 30-10-2020 | - |
Loopbaan van Scott Dylla
Eerdere bekende functies van Scott Dylla
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | 01-01-2008 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2008 | - | |
| Oprichter | 01-01-2008 | - |
Opleiding van Scott Dylla
| University of Minnesota | Undergraduate Degree |
| The University of Alabama at Birmingham | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KINETA, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Health Technology |
Driver Bioengineering, Inc.
Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Health Technology |
3D Bio Holdings, Inc.
3D Bio Holdings, Inc. Packaged SoftwareTechnology Services 3D Bio Holdings, Inc. develops term clinical applications. It focuses on whole tissue living implants. The company was founded by Hod Lipson, Larry Bonassar and Daniel L. Cohen and is headquartered in Brooklyn, NY. | Technology Services |
- Beurs
- Insiders
- Scott Dylla
- Ervaring
